NEW YORK, NY – Two prominent biotechnology companies, Vertex Pharmaceuticals and CRISPR Therapeutics, both led by Indian American CEOs, have been named to TIME’s 2025 list of the 100 Most Influential ...

Vertex Pharmaceuticals (VRTX) just checked several big boxes at once, with upbeat pediatric data for CASGEVY, fresh momentum in its kidney disease program, and a wave of investor interest following ...

Insiders were net buyers of Vertex, Inc.'s (NASDAQ:VERX ) stock during the past year. That is, insiders bought more stock than they sold. While insider transactions are not the most important thing ...

NOT A HOTEL Co., Ltd. has launched two new hotel brands, HERITAGE and vertex, expanding beyond shared ownership into public hotel offerings The first HERITAGE project will involve renovating the ...

A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston, Massachusetts, U.S., October 23, 2019. REUTERS/Brian Snyder Dec 6 (Reuters) - Vertex Pharmaceuticals said on ...

--Currently up two consecutive days; up 7.5% over this period --Best two day stretch since the two days ending Dec. 14, 2023, when it rose 13.66% --Up 13.61% year-to-date; on pace for best year since ...

Robots may not be taking the place of researchers in lab coats running clinical trials anytime soon, but AI is playing an increasingly important role in drug discovery efforts. That’s the message ...

This strengthens Google’s position against rivals such as Microsoft and AWS as enterprises seek faster, more reliable ways to deploy and manage AI agents. Google Cloud has updated its Vertex AI Agent ...

During Vertex’s third-quarter presentation, Chief Commercial Officer Duncan McKechnie cited several numbers that suggest the launch of its long-awaited, non-opioid pain reliever Journavx is trending ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...

Vertex Pharmaceuticals’VRTX-1.24%decrease; red down pointing triangle stock fell in post-market trading Monday, after the company said it would not progress a next-generation pain treatment into ...